Human Pro-MMP-10 Quantikine ELISA Kit
| Name | Human Pro-MMP-10 Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DM1000 |
| Category | ELISA Kit |
| Prices | $479.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (50 uL), Serum (25 uL), Heparin Plasma (25 uL) |
| Sensitivity | 15.1 pg/mL |
| Range | 78.1 - 5,000 pg/mL (Cell Culture Supernates, Serum, Heparin Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human Pro-MMP-10 Immunoassay is a 4.5 hour solid phase immunoassay designed to measure pro-MMP-10 in cell culture supernates, serum, and plasma |
| Gene | MMP10 |
| Supplier Page | Shop |
Product images
Product References
A multiplex immunoassay for the non-invasive detection of bladder cancer. - A multiplex immunoassay for the non-invasive detection of bladder cancer.
Shimizu Y, Furuya H, Bryant Greenwood P, Chan O, Dai Y, Thornquist MD, Goodison S, Rosser CJ. J Transl Med. 2016 Jan 30;14:31.
Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of - Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of
Chen CH, Chang AY, Li SH, Tsai HT, Shiu LY, Su LJ, Wang WL, Chiu TJ, Luo SD, Huang TL, Chien CY. Mol Cancer. 2015 Apr 12;14:83.
MMP-1 and Pro-MMP-10 as potential urinary pharmacodynamic biomarkers of - MMP-1 and Pro-MMP-10 as potential urinary pharmacodynamic biomarkers of
Du X, Lin BC, Wang QR, Li H, Ingalla E, Tien J, Rooney I, Ashkenazi A, Penuel E, Qing J. Clin Cancer Res. 2014 Dec 15;20(24):6324-35.
Primary human acute myelogenous leukemia cells release matrix metalloproteases - Primary human acute myelogenous leukemia cells release matrix metalloproteases
Reikvam H, Hatfield KJ, Oyan AM, Kalland KH, Kittang AO, Bruserud O. Eur J Haematol. 2010 Mar;84(3):239-51.
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix - Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix
Lorente L, Martin MM, Labarta L, Diaz C, Sole-Violan J, Blanquer J, Orbe J, Rodriguez JA, Jimenez A, Borreguero-Leon JM, Belmonte F, Medina JC, Lliminana MC, Ferrer-Aguero JM, Ferreres J, Mora ML, Lubillo S, Sanchez M, Barrios Y, Sierra A, Paramo JA. Crit Care. 2009;13(5):R158.
Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix - Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix
McLennan SV, Kelly DJ, Schache M, Waltham M, Dy V, Langham RG, Yue DK, Gilbert RE. Kidney Int. 2007 Aug;72(4):481-8. Epub 2007 Jun 6.
C-reactive protein induces matrix metalloproteinase-1 and -10 in human - C-reactive protein induces matrix metalloproteinase-1 and -10 in human
Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodriguez JA, Diez J, Libby P, Paramo JA. J Am Coll Cardiol. 2006 Apr 4;47(7):1369-78. Epub 2006 Mar 20.
Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase - Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase
Barksby HE, Milner JM, Patterson AM, Peake NJ, Hui W, Robson T, Lakey R, Middleton J, Cawston TE, Richards CD, Rowan AD. Arthritis Rheum. 2006 Oct;54(10):3244-53.
Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in - Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in
Behera AK, Hildebrand E, Scagliotti J, Steere AC, Hu LT. Infect Immun. 2005 Jan;73(1):126-34.
CXCL12-CXCR4 interactions modulate prostate cancer cell migration, - CXCL12-CXCR4 interactions modulate prostate cancer cell migration,
Singh S, Singh UP, Grizzle WE, Lillard JW Jr. Lab Invest. 2004 Dec;84(12):1666-76.